Iron chelators as mitophagy agents: Potential and limitations.

Area of Science:

• Cellular Biology
• Biochemistry
• Pathophysiology

Background:

• Mitochondrial autophagy (mitophagy) is vital for cellular homeostasis, function, and survival.
• Dysregulation of mitophagy is implicated in severe diseases like cancer, neurodegeneration, and cardiovascular conditions.
• Targeting mitophagy is a significant focus in biological and medical research.

Purpose of the Study:

• To thoroughly review the intricate relationships between iron homeostasis and mitophagy.
• To critically evaluate the therapeutic potential of mitophagy chelators in various disease contexts.

Main Methods:

• Literature review and synthesis of existing research on mitophagy and iron metabolism.
• Analysis of studies investigating the interplay between intracellular iron levels and mitophagy regulation.
• Critical assessment of preclinical and clinical data on mitophagy chelator efficacy.

Main Results:

• Mitochondria play a central role in regulating iron homeostasis.
• Alterations in intracellular chelatable iron levels can modulate mitophagy induction or repression.
• Emerging evidence suggests mitophagy chelators hold therapeutic promise for specific diseases.

Conclusions:

• The interplay between iron homeostasis and mitophagy is a critical area for understanding cellular health and disease.
• Targeting this relationship offers novel therapeutic avenues for diseases associated with mitophagy dysfunction.
• Further research into mitophagy chelators is warranted to fully realize their clinical potential.